00:08 27.04.26
Erstelle meine Watchlist und Depot login | Registrieren
Amgen Inc US0311621009

Amgen "neutral"

26.09.07 - Robert W. Baird

NEW YORK, September 26 (newratings.com) - In a research note published yesterday, analysts at Robert W Baird reiterate their "neutral" rating on Amgen Inc (AMGN). The target price is set to $57.

                                                                                                                        

Verbessern Sie newratings! Was könnte newratings besser machen?